COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis
Considering vaccine effectiveness in people living with HIV and/or who inject drugs
View PublicationFiltrer par:
Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIV
Considering preventative behaviour practices with respect to COVID-19 among people living with HIV
View PublicationMindfulness and cognitive training interventions that address intersecting cognitive and aging needs of older adults
Considering mindfulness and cognitive training interventions are promising models to address impacts (e.g., anxiety and stress) of cognitive impairment among older adults.
View PublicationKnowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary Study
Considering cannabinoid concentration knowledge among PLWH
View PublicationBaseline characteristics of a prospective cohort study of aging and cardiovascular diseases among people living with HIV
Reporting the baseline characteristics of participants in the Canadian HIV and Aging Cohort Study and presenting amendments to the initial protocol.
View PublicationSyndemic Factors and Lifetime Bidirectional Intimate Partner Violence Among Gay, Bisexual, and Other Sexual Minority Men
Considering associations between syndemic factors and lifetime bidirectional IPV among GBM in three Canadian cities to inform future interventions.
View PublicationImmunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV
Investigating the immunogenicity of COVID-19 vaccines and their effects on HIV reservoirs.
View PublicationRole of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort
Considering the contribution of metabolic dysfunction-associated steatotic liver disease to incident Advanced chronic liver disease in people living with HIV.
View PublicationPlasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremia
Considering whether gp120 contributs to chronic inflammation, immune dysfunction, and sub-clinical cardiovascular disease in participants of the Canadian HIV and Aging cohort
View PublicationAntibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)
Comparing COVID-19 vaccine-induced antibody neutralization capacity in PLWH vs. HIV-negative individuals following two vaccine doses
View Publication